*If You Own FCEL, GPS, GILD Then Click Here to Join Our Community Of Traders
The Market Signal was created as a platform to help investors, if you own (NASDAQ:FCEL), (NYSE:GPS) or (NASDAQ:GILD) and want to join the fastest growing community of investors on the web then sign up to the link below. Members get free access to the best investment tools in the world. Start trading like a pro today. This is a limited time offer so click the link below NOW.
https://themarketsignal.com/Free-Report/NOW
(Click link above or copy, paste and hit enter in your browser for your report)
FuelCell Energy to join the broad-market Russell 3000(R) Index
https://themarketsignal.com/Free-Report/FCEL
(Click link above or copy, paste and hit enter in your browser for your report)
FuelCell Energy Inc (NASDAQ:FCEL) has a market capitalization of $625.39 million and is one of the most popular stocks on Robinhood
FuelCell Energy has announced that it will join the broad-market Russell 3000(R) Index at the end of this year. The company will join the Russell indexes annual reconstitution after the US market opens on June 29.
Gap to release its Q2 2020 earnings
https://themarketsignal.com/Free-Report/GPS
(Click link above or copy, paste and hit enter in your browser for your report)
Gap Inc (NYSE:GPS) has a market capitalization of $5.47 billion and is one of the most popular stocks on Robinhood
Gap Inc has announced that it will release its Q2 2020 earnings results on August 27, 2020. The company has been taken to court by Black Rock Shopping Center for $120K unpaid rent. According to a SEC filing for April, the company said it had stopped paying rent for its 2,785 retail stores in North America due to the economic impact of the COVID-19.
Gilead Sciences increases production of remdesivir
https://themarketsignal.com/Free-Report/GILD
(Click link above or copy, paste and hit enter in your browser for your report)
Gilead Sciences, Inc. (NASDAQ:GILD) has a market capitalization of $85.94 billion and is one of the most popular stocks on Robinhood
Gilead has stepped its production for the antiviral drug remdesivir. It is the first treatment Gilead has stepped its production for the antiviral drug remdesivir. It is the first treatment that has shown to be effective in the fight against COVID-19. The company announced that it has increased production by 50% since January and expects to meet the growing global demand by October. The company says it will produce two million treatments by the end of 2020.
Please email or contact us for any edits or errors relating to this stock market news.
If you would like information on using our press release distribution service aimed at helping investors with the best stocks to buy and how to create your own stock portfolio. We cover the US Stock Market, Canadian Stock Market, the Australian Stock Market and other Stock Market news.
We will get back to you within 24 hours.
COMTEX_369226602/2700/2020-08-11T09:02:17
Is there a problem with this press release? Contact the source provider Comtex at editorialpr@comtex.com.
